Hybrid capture 2 assay based evaluation of high-risk HPV status in healthy women of North-East India

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 2, 2014, Pages 861-865

  Rai, Avdhesh Kumar ^a   Das, Debabrata ^a   Kataki, Amal Chandra ^a   Barmon, Debabrata ^a   Aggarwal, Dippy ^b   Deka, Pankaj ^a   Shrivastava, Sushruta ^a   Sharma, Jagannath Dev ^a   Sarma, Anupam ^a   Baruah, Upasana ^a   Sharma, Mousumi ^a  

^a A Unit of Tata Memorial Centre   (India)

^b Department of Obstetrics and Gynaecology Hayat Multi Speciality Hospital   (India)

Author keywords

HC2 assay; Healthy women of North East India; High risk HPV

Indexed keywords

VIRUS DNA;

ADULT; AGED; ARTICLE; CANCER STAGING; DIAGNOSTIC KIT; EVALUATION STUDY; FEMALE; FOLLOW UP; GENETICS; GENOTYPE; HUMAN; INDIA; ISOLATION AND PURIFICATION; MIDDLE AGED; PAPILLOMA VIRUS; PAPILLOMAVIRUS INFECTION; PATHOLOGY; PILOT STUDY; POLYMERASE CHAIN REACTION; PROGNOSIS; UTERINE CERVIX; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX TUMOR; VAGINA SMEAR; VIROLOGY; YOUNG ADULT;

ADULT; AGED; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; DNA, VIRAL; FEMALE; FOLLOW-UP STUDIES; GENOTYPE; HUMANS; INDIA; MIDDLE AGED; NEOPLASM STAGING; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PILOT PROJECTS; POLYMERASE CHAIN REACTION; PROGNOSIS; REAGENT KITS, DIAGNOSTIC; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS; YOUNG ADULT;

EID: 84894661745     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.2.861     Document Type: Article

References (29)

1. Arbyn M, Roelens J, Simoens C, et al (2013). Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions. Cochrane Database Syst Rev, 3, 8054.
2. Basu P, Mittal S, Bhaumik S, et al (2013). Prevalence of high-risk human papillomavirus and cervical intraepithelial neoplasias in a previously unscreened population-a pooled analysis from three studies. Int J Cancer, 132, 1693-9.
3. Bhatla N, Dar L, Patro AR, et al (2009). Can human papillomavirus DNA testing of self-collected vaginal samples compare with physician-collected cervical samples and cytology for cervical cancer screening in developing countries? Cancer Epidemiol, 33, 446-50.
4. Bhatla N, Puri K, Joseph E, et al (2013). Association of Chlamydia trachomatis infection with human papillomavirus (HPV) & cervical intraepithelial neoplasia-a pilot study. Indian J Med Res, 137, 533-9.
5. Bhatla N, Puri K, Kriplani A, et al (2012). Adjunctive testing for cervical cancer screening in low resource settings. Aust N Z J Obstet Gynaecol, 52, 133-9.
6. Brun-Micaleff E, Coffy A, Rey V, et al (2013). Cervical cancer screening by cytology and human papillomavirus testing during pregnancy in French women with poor adhesion to regular cervical screening. J Med Virol, 86, 536-45.
7. Cubie HA, Cuschieri K (2013). Understanding HPV tests and their appropriate applications. Cytopathology, 24, 289-308.
8. Das D, Rai AK, Kataki AC, et al (2013). Nested multiplex PCR based detection of human papillomavirus in cervical carcinoma patients of North-East India. Asian Pac J Cancer Prev, 14, 785-90.
9. Datta P, Bhatla N, Dar L, et al (2010). Prevalence of human papillomavirus infection among young women in North India. Cancer Epidemiol, 34, 157-61.
10. Ferlay J, Shin HR, Bray F, et al (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer, 127, 2893-917.
11. Ferreccio C, Barriga MI, Lagos M, et al (2012). Screening trial of human papillomavirus for early detection of cervical cancer in Santiago. Int J Cancer, 132, 916-23.
12. Gillio-Tos A, De Marco L, Carozzi F M, et al (2013). New Technologies for Cervical Cancer of the Hybrid Capture 2 Test: Data from the (NTCC) Study. J Clin Microbiol, 51, 2901-7.
13. Giorgi-Rossi P, Franceschi S, Ronco G (2012). HPV prevalence and accuracy of HPV testing to detect high-grade cervical intraepithelial neoplasia. Int J Cancer, 130, 1387-94.
14. Goldie SJ, Gaffikin L, Goldhaber-Fiebert JD, et al (2005). Cost effectiveness of cervical cancer screening in five developing countries. N Engl J Med, 353, 2158-68.
15. Jentschke M, Soergel P, Hillemanns P (2013). Evaluation of a multiplex real time PCR assay for the detection of human papillomavirus infections on self-collected cervicovaginal lavage samples. J Virol Methods, 193, 131-4.
16. Katyal S, Mehrotra R (2011). Complementary procedures in cervical cancer screening in low resource settings. J Obstet Gynaecol India, 61, 436-8.
17. Kitchener HC, Almonte M, Thomson C, et al (2009). HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial. Lancet Oncol, 10, 672-82.
18. Leinonen M, Nieminen P, Kotaniemi-Talonen L, et al (2009). Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting. J Natl Cancer Inst, 101, 1612-23.
19. Meijer CJ, Berkhof J, Castle PE, et al (2009). Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older. Int J Cancer, 124, 516-20.
20. Pandey S, Mishra M, Chandrawati (2012). Human papillomavirus screening in north Indian women. Asian Pac J Cancer Prev, 13, 2643-6.
21. Piyathilake CJ, Badiga S, Paul P, et al (2010). Indian women with higher serum concentrations of folate and vitamin B12 are significantly less likely to be infected with carcinogenic or high-risk (HR) types of human papillomaviruses (HPVs). Int J Womens Health, 2, 7-12.
22. Ronco G, Giorgi-Rossi P, Carozzi F, et al (2008). Results at recruitment from a randomized controlled trial comparing human papillomavirus testing alone with conventional cytology as the primary cervical cancer screening test. J Natl Cancer Inst, 100, 492-501.
23. Sarian LO, Derchain S, Shabalova I, et al (2010). Optional screening strategies for cervical cancer using standalone tests and their combinations among low-and medium-income populations in Latin America and Eastern Europe. J Med Screen, 17, 195-203.
24. Schiffman M, Wentzensen N, Wacholder S, et al (2011). Human papillomavirus testing in the prevention of cervical cancer. J Natl Cancer Inst, 103, 368-83.
25. Sowjanya AP, Jain M, Poli UR, et al (2005). Prevalence and distribution of high-risk human papilloma virus (HPV) types in invasive squamous cell carcinoma of the cervix and in normal women in Andhra Pradesh, India. BMC Infect Dis, 5, 116.
26. Sowjanya AP, Paul P, Vedantham H, et al (2009). Suitability of self-collected vaginal samples for cervical cancer screening in periurban villages in Andhra Pradesh, India. Cancer Epidemiol Biomarkers Prev, 18, 1373-8.
27. Tao K, Yan J, Yang H, et al (2013). Comparative study of the Cervista and Hybrid Capture 2 methods in detecting high-risk human papillomavirus in cervical lesions. Diagn. Cytopathol. [Epub ahead of print???].
28. Three-Year Report of Population Based Cancer Registries 2009-2011: Incidence and Distribution of Cancer. (2013). NCDIR-NCRP (ICMR), Bangalore.
29. Zhao C, Weng B, Li Z, Yang H, Austin RM (2013). Follow-up outcomes of a large cohort of low-risk women with negative imaged liquid-based cytology and negativeHPV test results. Am J Clin Pathol, 139, 32-8.